Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05453526 · ClinicalTrials.gov registry record
The Bronx-Valve Registry
A clinical trial, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- 330,570
- Enrollment target
NCT05453526: Completed study, sponsored by Montefiore Medical Center.
NCT05453526 is a clinical trial that has completed, run by Montefiore Medical Center. The registered enrollment target is 330,570 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05453526 has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- 330,570 participants
- Enrollment target
Study Summary
The Bronx-Valve Registry is designed to collect and assess data on all patients with valvular diseases referred to Montefiore Medical Center for echocardiographic exams. Valvular heart disease (VHD) is a major focus of cardiovascular medicine, but limited data are available for racial and ethnic minorities. The aim was to assess the burden and clinical correlates of VHD in a highly diverse area of the United States.
Primary Outcome
Baseline characteristics among pre-defined racial/ethnical groups will be compared for each valvular heart disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330,570 participants |
| Start Date | 2010-01-01 |
| Est. Completion | 2019-12-31 |
What the finished NCT05453526 record still lists
NCT05453526 is an observational study that tracks outcomes without assigning an intervention. Its 330,570 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT05453526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05453526 about?
NCT05453526 is a clinical study titled "The Bronx-Valve Registry". The Bronx-Valve Registry is designed to collect and assess data on all patients with valvular diseases referred to Montefiore Medical Center for echocardiographic exams. Valvular heart disease (VHD) is a major focus of cardiovascular medicine, but limited data are available for racial and ethnic min...
What is the current status of trial NCT05453526?
This trial is currently completed. The enrollment target is 330,570 participants. The study started on 2010-01-01. Estimated completion is 2019-12-31.
Who is sponsoring clinical trial NCT05453526?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI